OMNICELL, INC.
OMCL US68213N1090
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
51% | -72% | -27% | 19% | 2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Manley Corey J EX VP |
33.25 USD |
3,880 Sold |
129,010 USD |
12/09/2025 | 12/09/2025 |
Lipps Randall A CEO |
33.13 USD |
10,561 Bought |
349,874 USD |
14/03/2025 | 14/03/2025 |
Parrish Mark W O |
47.30 USD |
12,000 Sold |
567,638 USD |
10/12/2024 | 10/12/2024 |